Regulation of the mdm2 oncogene by thyroid hormone receptor

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 864-872

  Qi, Jian Shen ^a   Yuan, Yaping ^a   Desai Yajnik, Vandana ^a   Samuels, Herbert H ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INTRON; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION;

EID: 0032907950     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.1.864     Document Type: Article

References (70)

1. Au-Fliegner, M., E. Helmer, J. Casanova, B. M. Raaka, and H. H. Samuels. 1993. The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol. Cell. Biol. 13:5725-5737.
2. Bagchi, M. K., S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1987. Purification and characterization of chicken ovalbumin gene upstream promoter transcription factor from homologous oviduct cells. Mol. Cell. Biol. 7:4151-4158.
3. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. U. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
4. Barak, Y. T., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461-468.
5. Barettino, D., T. H. Bugge, P. Bartunek, M. V. Ruiz, V. Sonntag-Buck, H. Beug, M. Zenke, and H. G. Stunnenberg. 1993. Unliganded T3R, but not its oncogenic variant, v-crbA, suppresses RAR-dependent transactivation by titrating out RXR. EMBO J. 12:1343-1354.
6. Brent, G. A., J. W. Harney, Y. Chen, R. L. Warne, D. D. Moore, and P. R. Larsen. 1989. Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element. Mol. Endocrinol. 3:1996-2004.
7. Brent, G. A., P. R. Larsen, J. W. Harney, R. J. Koenig, and D. D. Moore. 1989. Functional characterization of the rat growth hormone promoter elements required for induction by thyroid hormone with and without a cotransfected beta type thyroid hormone receptor. J. Biol. Chem. 264:178-182.
8. Cahilly-Snyder, L., T. Yang-Feng, V. Francke, and D. L. George. 1987. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat. Cell Mol. Genet. 13:235-244.
9. Casanova, J., Z. D. Horowitz, R. P. Copp, W. R. McIntyre, A. Pascual, and H. H. Samuels. 1984. Photoaffinity labeling of thyroid hormone nuclear receptors: influence of n-butyrate and analysis of the half-lives of the 57,000 and 47,000 molecular weight receptor forms. J. Biol. Chem. 259:12084-12091.
10. Chatterjee, V. K. K., J.-K. Lee, A. Rentoumis, and J. L. Jameson. 1989. Negative regulation of the thyroid stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc. Natl. Acad. Sci. USA 86:9114-9118.
11. Cooney, A. J., X. Leng, S. Y. Tsai, B. W. O'Malley, and M.-J. Tsai. 1993. Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D. thyroid hormone, and retinoic acid receptors. J. Biol. Chem. 268:4152-4160.
12. 3, thyroid hormone, and retinoic acid receptors. Mol. Cell. Biol. 12:4153-4163.
13. Deavergne, B., K. J. Petty, and V. M. Nikodem. 1991. Functional characterization and receptor binding studies of the malic enzyme thyroid hormone response element. J. Biol. Chem. 266:1006-1013.
14. Desai-Yajnik, V., E. Hadzic, P. Modlinger, S. Malhotra, G. Gechlik, and H. H. Samuels. 1995. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator. J. Virol. 69:5103-5112.
15. Desai-Yajnik, V., and H. H. Samuels. 1993. The NF-κB and Sp1 DNA motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Mol. Cell. Biol. 13:5057-5069.
16. 1 cell-cycle arrest. Oncogene 11:2445-2449.
17. El-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Human genomic DNA sequences define a consensus binding site for p53. Nat. Genet. 1:44-49.
18. Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
19. Farkharzadeh, S. S., S. P. Trusko, and D. L. George. 1991. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10:1565-1569.
20. Fields, S., and S. K. Jang. 1990. The p53 proto-oncogene can act as a suppressor of transformation. Science 249:1046-1049
21. Finlay, C. A. 1993. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13:301-306.
22. Flug, F., R. P. Copp, J. Casanova, Z. D. Horowitz, L. Janocko, M. Plotnick, and H. Samuels. 1987. cis-acting elements of the rat growth hormone gene which mediate basal and regulated expression by thyroid hormone. J. Biol. Chem. 262:6373-6382.
23. Forman, B. M., J. Casanova, B. M. Raaka, J. Ghysdael, and H. H. Samuels. 1992. Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol. Endocrinol. 6:429-442.
24. Forman, B. M., and H. H. Samuels. 1990. Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. Mol. Endocrinol. 4:1293-1301.
25. Forman, B. M., and H. H. Samuels. 1991. pEXPRESS: a family of expression vectors containing a single transcription unit active in prokaryotes, eukaryotes and in vitro. Gene 105:9-15.
26. Forman, B. M., C.-R. Yang, M. Au, J. Casanova, J. Ghysdael, and H. H. Samuels. 1989. A domain containing leucine zipper like motifs mediates novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol. Endocrinol. 3:1610-1626.
27. Forman, B. M., C.-R. Yang, F. Stanley, J. Casanova, and H. H. Samuels. 1988. c-erbA protooncogenes mediate thyroid hormone-dependent and -independent regulation of the rat growth hormone and prolactin genes. Mol. Endocrinol. 2:902-911.
28. Geffner, M. E., F. Su, N. Ross, J. M. Hershman, C. V. Dop, J. B. Menke, E.-H. Hao, R. K. Stanzak, T. Eaton, H. H. Samuels, and S. J. Usala. 1993. An arginine to histidine mutation in codon 311 of the c-erbAβ gene results in a mutant thyroid hormone receptor which does not mediate a dominant negative phenotype. J. Clin. Invest. 91:538-546.
29. Guernsey, D. L., and P. B. Fisher. 1990. Thyroid hormone and neoplastic transformation. Crit. Rev. Oncog. 1:389-408.
30. Hadzic, E., V. Desai-Yajnik, E. Helmer, S. Guo, S. Wu, N. Koudinova, J. Casanova, B. M. Raaka, and H. H. Samuels. 1995. A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor a is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol. Cell. Biol. 15:4507-1517.
31. Haines, D. S., J. E. Landers, L. J. Engle, and D. L. George. 1994. Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell. Biol. 14:1171-1178.
32. Halperin, Y., M. I. Surks, and L. E. Shapiro. 1990. L-Triiodothyronine (T3) regulates cellular growth rate, growth hormone production, and levels of nuclear T3 receptors via distinct dose-response ranges in cultured GC cells. Endocrinology 126:2321-2326.
33. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
34. Hinds, P. W., C. A. Finlay, R. S. Quartin, S. J. Baker, E. R. Fearon, B. Vogelstein, and A. J. Levine. 1990. Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells: a comparison of the "hot spot" mutant phenotypes. Cell Growth Differ. 1:571-580.
35. Hodin, R., M. A. Lazar, B. I. Wintman, D. S. Darling, R. J. Koenig, P. R. Larsen, D. D. Moore, and W. W. Chin. 1989. Identification of a thyroid hormone receptor that is pituitary-specific. Science 244:76-79.
36. Horowitz, Z. D., H. Sahnoun, A. Pascual, J. Casanova, and H. H. Samuels. 1988. Analysis of photoaffinity label derivatives to probe thyroid hormone receptor in human fibrohlasts. GH1 cells and soluble receptor preparations. J. Biol. Chem. 263:6636-6642.
37. Horowitz, Z. D., C-R. Yang, B. M. Forman, J. Casanova, and H. H. Samuels. 1989. Characterization of the domain structure of chick c-erbA by deletion mutation: in vitro translation and cell transfection studies. Mol. Endocrinol. 3:148-156.
38. Juven, T., Y. Barak, A. Zauberman, D. L. George, and M. Oren. 1993. Wild-type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8:3411-3416.
39. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
40. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
41. Landanyl, M., C. Cha, R. Lewis, S. C. Jhanwar, A. G. Hacos, and J. H. Healy. 1993. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 53:16-18.
42. Landers, J. E., D. S. Haines, J. F. Strauss III, and D. L. George. 1994. Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 9:2745-2750.
43. Lazar, M. A. 1993. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 14:184-193.
44. Leveillard, T., and B. Wasylyk. 1997. The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter. J. Biol. Chem. 272:30651-30661.
45. Marks, M. S., B.-Z. Levi, J. H. Segars, P. H. Driggers, S. Hirschfeld, T. Nagata, E. Appella, and K. Ozato. 1992. H-2RIIBP expressed from a baculovirus vector binds to multiple hormone response elements. Mol. Endocrinol. 6:219-230.
46. Martin, K., D. Trouche, C. Hagemeler, T. S. Sorensen, N. B. L. Thangue, and T. Kouzarides. 1995. Stimulation of E2F1/DP1 transcriptional activity by mdm2 oncoprotein. Nature 375:691-694.
47. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Livine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
48. Naar, A. M., J.-M. Boutin, S. M. Lipkin, V. C. Yu, J. M. Holloway, C. K. Glass, and M. G. Rosenfeld. 1991. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65:1267-1279.
49. Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
50. Olson, D., V. Marechal, J. Momand, J. Chen, C. Romocki, and A. J. Livine. 1993. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 8:2353-2360.
51. Qi, J.-S., V. Desai-Yajnik, M. E. Greene, B. M. Raaka, and H. H. Samuels. 1995. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transaclivation. Mol. Cell. Biol. 15:1817-1825.
52. Qi, J.-S., V. Desai-Yajnik, Y. Yuan, and H. H. Samuels. 1997. Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression. Mol. Cell. Biol. 17:7195-7207.
53. Samuels, H. H., B. M. Forman, Z. D. Horowitz, and Z.-S. Ye. 1988. Regulation of gene expression by thyroid hormone. J. Clin. Invest. 81:957-967.
54. Sap, J., L. deMagistris, H. Stunnenberg, and B. Vennstrom. 1990. A major thyroid hormone response element in the third intron of the rat growth hormone gene. EMBO J. 9:887-896.
55. Sap, J., A. Munoz, J. Schmitt, H. Stunnenberg, and B. Vennstrom. 1989. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature 340:242-244.
56. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 61:1129-1136.
57. Selmi, S., and H. H. Samuels. 1991. Thyroid hormone receptor/c-erbA and v-erbA: a single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation. J. Biol. Chem. 266:11589-11593.
58. Shaulian, E., D. Resnilzky, O. Shifman, G. Blandino, A. Amsterdam, A. Yayon, and M. Oren. 1997. Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene 15:2717-2725.
59. Soussi, T., C. C. deFromentel, and P. May. 1990. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945-952.
60. Sturzbecher, H. W., R. Brain, C. Addison, K. Rudge, M. Remm, M. Grimaldi, E. Keenan, and J. R. Jenkins. 1992. A C-terminal α-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7:1513-1523.
61. Subler, M. A., D. W. Martin, and S. Deb. 1994. Overlapping domains on the p53 protein regulate its transcriptional activation and repression functions. Oncogene 9:1351-1359.
62. Umesono, K., and R. M. Evans. 1989. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57:1139-1146.
63. Umesono, K., V. Giguere, C. K. Glass, M. G. Rosenfeld, and R. M. Evans. 1988. Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature 336:262-265.
64. Umesono, K., K. K. Murakami, C. C. Thompson, and R. M. Evans. 1991. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D receptors. Cell 65:1255-1266.
65. Wang, L-H., S. Y. Tsai, R. G. Cook, W. G. Beattle, M.-J. Tsai, and B. W. O'Malley. 1989. COUP transcription factor is a member of the steroid receptor superfamily. Nature 340:163-166.
66. Wang, Y., M. Reed, P. Wang, J. E. Stenger, G. Mayr, M. E. Andersen, J. F. Schwedes, and P. Tegtmeyer. 1993. p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7:2575-2586.
67. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
68. Xiao, Z. X., J. Chen, A. J. Livine, N. Modjtahedi, J. Xing, W. R. Sellers, and D. M. Livingston. 1995. Interaction between the retinoblastoma protein and oncoprotein mdm2. Nature 375:694-697.
69. Zambetti, G. P., J. Bargonetti, K. Walker, C. Prives, and A. J. Levine. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev. 6:1143-1152
70. Zauberman, A., D. Flusberg, V. Haupt, Y. Barak, and M. Oren. 1995. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res. 23:2584-2592.